| 1. |
Kirkitadze, M. D., Bitan, G., and Teplow, D. B. (2002) Paradigm shifts in Alzheimer's disease and other neurodegenerative
disorders: the emerging role of oligomeric assemblies. J. Neurosci. Res.
69, 567–577.
|
| |
| 2. |
Koo, E. H., Lansbury, P. T., and Kelly, J. W. (1999) Amyloid diseases: abnormal protein aggregation in neurodegeneration.
Proc. Natl. Acad. Sci. USA
96, 9989–9990.
|
| |
| 3. |
Selkoe, D. J. (1999) Translating cell biology into therapeutic advances in Alzheimer's disease. Nature
399, A23–A31.
|
| |
| 4. |
Klein, W. L., Krafft, G. A., and Finch, C. E. (2001) Targeting small Aβ oligomers: the solution to an Alzheimer's disease
conundrum? Trends Neurosci.
24, 219–224.
|
| |
| 5. |
Walsh, D. M., Klyubin, I., Fadeeva, J. V., et al. (2002) Naturally secreted oligomers of amyloid β protein potently inhibit
hippocampal long-term potentiation in vivo. Nature
416, 535–539.
|
| |
| 6. |
Baskakov, I. V., Legname, G., Baldwin, M. A., Prusiner, S. and Cohen, F. E. (2002) Pathway complexity of prion protein assembly
into amyloid. J. Biol. Chem.
277, 21140–21148.
|
| |
| 7. |
Lashuel, H. A., Petre, B. M., Wall, J., et al. (2002) α-synuclein, especially the Parkinson's disease-associated mutants,
forms pore-like annular and tubular protofibrils. J. Mol. Biol.
322, 1089–1102.
|
| |
| 8. |
Sanchez, I., Mahlke, C., and Yuan, J. Y. (2003) Pivotal role of oligomerization in expanded polyglutamine neurodegenerative
disorders. Nature
421, 373–379.
|
| |
| 9. |
Roher, A. E., Chaney, M. O., Kuo, Y. M., et al. (1996) Morphology and toxicity of Aβ(1-42) dimer derived from neuritic and
vascular amyloid deposits of Alzheimer's disease. J. Biol. Chem.
271, 20631–20635.
|
| |
| 10. |
Walsh, D. M., Lomakin, A., Benedek, G. B., Condron, M. M., and Teplow, D. B. (1997) Amyloid β-protein fibrillogenesis—detection
of a protofibrillar intermediate. J. Biol. Chem.
272, 22364–22372.
|
| |
| 11. |
Lomakin, A., Chung, D. S., Benedek, G. B., Kirschner, D. A., and Teplow, D. B. (1996) On the nucleation and growth of amyloid
β-protein fibrils: detection of nuclei and quantitation of rate constants. Proc. Natl. Acad. Sci. USA
93, 1125–1129.
|
| |
| 12. |
Garzon-Rodriguez, W., Sepulveda-Becerra, M., Milton, S., and Glabe, C. G. (1997) Soluble amyloid Aβ-(1-40) exists as a stable
dimer at low concentrations. J. Biol. Chem.
272, 21037–21044.
|
| |
| 13. |
Huang, T. H., Yang, D. S., Plaskos, N. P., et al. (2000) Structural studies of soluble oligomers of the Alzheimer β-amyloid
peptide. J. Mol. Biol.
297, 73–87.
|
| |
| 14. |
Zagorski, M. G., Shao, H., Ma, K., et al. (2000) Aβ(1-40) and Aβ(1-42) adopt remarkably stable monomeric and extended structures
in water solution at neutral pH. Neurobiol. Aging
21, S10–S11 (Abstract 48).
|
| |
| 15. |
Bitan, G., Lomakin, A., and Teplow, D. B. (2001) Amyloid β-protein oligomerization: prenucleation interactions revealed by
photo-induced cross-linking of unmodified proteins. J. Biol. Chem.
276, 35176–35184.
|
| |
| 16. |
Fancy, D. A. and Kodadek, T. (1999) Chemistry for the analysis of protein-protein interactions: rapid and efficient cross-linking
triggered by long wavelength light. Proc. Natl. Acad. Sci. USA
96, 6020–6024.
|
| |
| 17. |
Fancy, D. A., Denison, C., Kim, K., et al. (2000) Scope, limitations and mechanistic aspects of the photo-induced cross-linking
of proteins by water-soluble metal complexes. Chem. Biol.
7, 697–708.
|
| |